US › Healthcare

Nuwellis Inc (NUWE)

US · Healthcare · Medical Devices

$0.550.00%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$2.0M

Revenue YoY

+14.1%

Net profit

$-4.8M

EPS

$-26.64

EPS estimate

$-23.80

Net margin

-245.2%

EPS came in at -26.64 against a street estimate of -23.80 — a miss of 11.9%.

Key statistics

Market cap

$2.5M

P/E

0.0

Forward P/E

0.0

P/B

0.18

Book value

$-3.58

EPS (TTM)

$435.92

52-week high

$172.90

52-week low

$0.67

50-day MA

$1.08

200-day MA

$31.94

Beta

0.09

Analyst view

with an average price target of $11.00.

Shareholding

Insiders

4.96%

Institutions

2.59%

Largest institutional holders

Fund	Stake
Sabby Management LLC	0.45%
UBS Group AG	0.12%
Tower Research Capital LLC	0.00%
SBI Securities Co Ltd	0.00%
Ankerstar Wealth, LLC	0.00%
DRW Securities, LLC	0.00%
Geode Capital Management, LLC	0.00%
Caitong International Asset Management Co., Limited.	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nuwellis Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.